To Shine a Light
for MPS

A powerful message advocating for education, awareness, and hope for those affected by Mucopolysaccharidoses (MPS) and related diseases.

By shining a light on these rare disorders, we can illuminate the path towards early diagnosis, effective treatments, and ultimately, cures. Together, we can provide hope and support to individuals and families impacted by MPS, ensuring a brighter future for all.

To Fight
for MPS

A call to fight for the rights of all MPS patients, regardless of their location or financial status, to have equitable access to early diagnosis, treatment, and support, providing them with the care and resources they need to thrive.

Our voices need to be loud, and our actions meaningful, as we advocate for change and support for those affected by MPS.

The average time to diagnosis for MPS can range from 3 to 10 years, leading to delayed treatment and management.
Early diagnosis and intervention are crucial for MPS patients to improve quality of life and prevent disease progression.
Clinical trials are ongoing for gene therapy and other novel treatments for MPS, showing promise for improved outcomes.

To Unite
for MPS

A rallying call for researchers, healthcare providers, policymakers, pharmaceutical companies, and the community at large to come together in the fight against Mucopolysaccharidoses (MPS) and related diseases.

By uniting our efforts, we can enhance our understanding, identify effective treatments, and ultimately improve the lives of patients and their families. Together, we can provide the support and compassion needed to uplift those affected by MPS, fostering a united front for progress and change.

MPS affects people of all ethnicities and demographics, but prevalence rates may vary among different populations.
Patients in underdeveloped countries face challenges accessing timely diagnosis, treatment, and supportive care due to limited healthcare resources.
Treatments for some types of MPS include enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT), which can help manage symptoms and improve quality of life.